Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hemogenyx Pharmaceuticals Plc. (OP:HOPHF)

2.330 UNCHANGED
Last Price Updated: 12:20 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Hemogenyx Pharmaceuticals Plc.

< Previous 1 2 3 Next >
Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Clearance to Initiate Pediatric Enrolment
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Signs Letter of Intent
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Third Patient Safety
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Opening of First Clinical Site
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Invitation to Participate at DCNY Summit
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Manufacturing Partnership with Made Scientific
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Result of Audit Tender
Via ACCESS Newswire
Hemogenyx raises £570,000 and Director's Dealing
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC - Third Patient Treated with HG-CT-1 CAR-T Therapy
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £250,000 and Director's Dealing
Via ACCESS Newswire
Hemogenyx Awarded Grant
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Clearance to Proceed with Pediatric Expansion
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director’s Dealing
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Final Results
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces First Patient Safety
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces First-in-Human Treatment with HG-CT-1
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes
Via ACCESS Newswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.